General Information of Drug Off-Target (DOT) (ID: OTD98O80)

DOT Name Mitochondrial ornithine transporter 2 (SLC25A2)
Synonyms Solute carrier family 25 member 2
Gene Name SLC25A2
UniProt ID
ORNT2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00153
Sequence
MKSGPGIQAAIDLTAGAAGGTACVLTGQPFDTIKVKMQTFPDLYKGLTDCFLKTYAQVGL
RGFYKGTGPALMAYVAENSVLFMCYGFCQQFVRKVAGMDKQAKLSDLQTAAAGSFASAFA
ALALCPTELVKCRLQTMYEMEMSGKIAKSHNTIWSVVKGILKKDGPLGFYHGLSSTLLQE
VPGYFFFFGGYELSRSFFASGRSKDELGPVHLMLSGGVAGICLWLVVFPVDCIKSRIQVL
SMYGKQAGFIGTLLSVVRNEGIVALYSGLKATMIRAIPANGALFVAYEYSRKMMMKQLEA
Y
Function
Mitochondrial transporter of the positively charged amino acids ornithine, lysine and arginine, and the neutral amino acid citrulline. In addition, transports the basic amino acids histidine, homoarginine, and asymmetric dimethylarginine (aDMA), but not symmetric DMA, and the D-forms of lysine, arginine, ornithine and histidine. Functions by both counter-exchange and uniport mechanisms.
Tissue Specificity Expressed in liver, testis, spleen, lung, pancreas, and small intestine and expressed poorly in other tissues.
Reactome Pathway
Urea cycle (R-HSA-70635 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Epigallocatechin gallate DMCGWBJ Phase 3 Epigallocatechin gallate increases the expression of Mitochondrial ornithine transporter 2 (SLC25A2). [1]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of Mitochondrial ornithine transporter 2 (SLC25A2). [3]
Mivebresib DMCPF90 Phase 1 Mivebresib increases the expression of Mitochondrial ornithine transporter 2 (SLC25A2). [3]
KOJIC ACID DMP84CS Investigative KOJIC ACID decreases the expression of Mitochondrial ornithine transporter 2 (SLC25A2). [4]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Mitochondrial ornithine transporter 2 (SLC25A2). [2]
------------------------------------------------------------------------------------

References

1 Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):166-75.
2 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
3 Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. PLoS One. 2022 Apr 29;17(4):e0266966. doi: 10.1371/journal.pone.0266966. eCollection 2022.
4 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.